COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 457: Articles 4561-4570  | Next

Mechanistic view on the influence of fluctuations in outdoor temperature on the worsening of the course of the disease and hospitalizations associated with the SARS-CoV-2 Omicron wave in 2022 in the Tomsk region, Russia
Ishmatov, A., Bart, A., Yakovlev, S.
10.1101/2023.01.04.23284173 — Posted: 2023-01-05
The Defense of Shangri-La: A Thought Experiment of Periodic Community-wide Screening in the Future Pandemic
Duan, A., Li, J., Yang, Z., HE, Y.
10.1101/2023.01.03.23284127 — Posted: 2023-01-05
In vivo activity of Sotrovimab against BQ.1.1 Omicron sublineage
Driouich, J.-S., Bernadin, O., Touret, F., de Lamballerie, X., Nougairede, A.
10.1101/2023.01.04.522629 — Posted: 2023-01-04
Bioinformatics Approaches to Determine the Effect of SARS-CoV-2 Infection on Patients with Intrahepatic Cholangiocarcinoma
Zhou, X., Huang, T., Yuan, K.
10.1101/2023.01.04.522709 — Posted: 2023-01-04
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-based Omicron COVID-19 Vaccination in Small Animal Models
Roth, N., Gergen, J., Kovacikova, K., Mueller, S., Ulrich, L., Schoen, J., Halwe, N. J., Fricke, C., Corleis, B., Dorhoi, A., Hoffmann, D., Beer, M., Maione, D., Petsch, B. W., Rauch, S.
10.1101/2023.01.04.521629 — Posted: 2023-01-04
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses
Soni, M. K., Migliori, E., Fu, J., Assal, A., Chan, H. T., Pan, J., Khatiwada, P., Ciubotariu, R., May, M. S., Pereira, M. R., De Giorgi, V., Sykes, M., Mapara, M. Y., Muranski, P.
10.1101/2023.01.03.519511 — Posted: 2023-01-04
The impact of the COVID-19 pandemic on health related quality of life in head and neck cancer survivors: an observational cohort study
Lissenberg-Witte, B., Jansen, F., Baatenburg de Jong, R. J., Lamers, F., Leemans, R., Oosting, S., Takes, R., Verdonck-de Leeuw, I.
10.1101/2023.01.03.23284145 — Posted: 2023-01-04
Early risk-assessment of pathogen genomic variants emergence
Susswein, Z., Johnson, K. E., Kassa, R., Parastaran, M., Peng, V., Wolansky, L., Scarpino, S. V., Bento, A. I.
10.1101/2023.01.02.23284123 — Posted: 2023-01-04
Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach
Hogan, A. B., Doohan, P., Wu, S. L., Olivera Mesa, D., Toor, J., Watson, O. J., Winskill, P., Charles, G., Barnsley, G., Riley, E. M., Khoury, D. S., Ferguson, N. M., Ghani, A.
10.1101/2023.01.03.23284131 — Posted: 2023-01-04
Machine Learning Algorithms to Fight the COVID-19 Pandemic
PATTNAIK, M., PATTNAIK, A., PATTNAIK, A.
10.1101/2022.12.31.22284091 — Posted: 2023-01-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).